Trends in clinical trials for olfactory dysfunction in the COVID-19 era.

Vickie J WangHisham AbdouAmar H ShethR Peter ManesRyan Rimmer

Published in: International forum of allergy & rhinology (2023)

Nearly half of all olfactory dysfunction (OD) clinical trials since 2010 are COVID-19-related. COVID-19-related OD trials are published significantly faster than COVID-19-unrelated trials. High-quality clinical trials and publications are crucial to discovering effective treatments.

Keyphrases

coronavirus disease
clinical trial
sars cov
respiratory syndrome coronavirus
oxidative stress
phase ii
systematic review
open label
study protocol